Large-scale testing (Phase 3)Study completedNCT02815670What this trial is testingReversal Dabigatran Anticoagulant Effect With IdarucizumabWho this might be right forHemorrhage Boehringer Ingelheim 1
Early research (Phase 1)UnknownNCT05788900What this trial is testingEvaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous AdministrationWho this might be right forAnticoagulant Blau Farmaceutica S.A. 68
Early research (Phase 1)Ended earlyNCT05788328What this trial is testingA Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult ParticipantsWho this might be right forHealthy Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT00119457What this trial is testingFactor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)Who this might be right forVenous ThromboembolismEmbolism and ThrombosisHip Fractures vTv Therapeutics 300
Early research (Phase 1)UnknownNCT05788913What this trial is testingEvaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous AdministrationWho this might be right forAnticoagulant Blau Farmaceutica S.A. 68
Testing effectiveness (Phase 2)Study completedNCT00107900What this trial is testingStudy of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip ReplacementWho this might be right forArthroplasty, Replacement, HipThrombosis Daiichi Sankyo 606
Early research (Phase 1)UnknownNCT04592822What this trial is testingA Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed ConditionWho this might be right forAnticoagulant Hong Kong WD Pharmaceutical Co., Limited 20
Not applicableUnknownNCT05150314What this trial is testingComparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking EnoxaparinWho this might be right forVenous Thromboembolic Disease University Hospital, Strasbourg, France 2,000
Not applicableUnknownNCT04462614What this trial is testingPossibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKAWho this might be right forChronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more CHU de Reims 49
Large-scale testing (Phase 3)Not Yet RecruitingNCT07454707What this trial is testingTesting a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ TrialWho this might be right forStroke, Ischemic Sunnybrook Health Sciences Centre 1,204
Early research (Phase 1)Study completedNCT01826266What this trial is testingEffects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of EdoxabanWho this might be right forAnticoagulant ReversalReversal of Edoxaban Induced Anticoagulation Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 83
Not applicableUnknownNCT04671160What this trial is testingImpact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.Who this might be right forAssessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis Medical University of Gdansk 80
Post-approval studies (Phase 4)Ended earlyNCT03678506What this trial is testingApixaban for Extended Anticoagulation (APIDULCIS)Who this might be right forVenous ThromboembolismAnticoagulants Arianna Anticoagulazione Foundation 800
Not applicableEnrolling By InvitationNCT07242326What this trial is testingSNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)Who this might be right forMedication AdherenceAtrial Fibrillation (AF)Direct Oral Anticoagulants (DOACs) Kotyora Family Medicine Health Management and Education Association 1,000
Early research (Phase 1)Study completedNCT05265676What this trial is testingBioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human SubjectsWho this might be right forHealthy Venus Remedies Limited 24
Not applicableLooking for participantsNCT07575867What this trial is testingCLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke PreventionWho this might be right forAtrial FibrillationStroke Prevention in Patients With Atrial FibrillationLeft Atrial Appendage Closure+4 more National Medical Research Center for Therapy and Preventive Medicine 464
Early research (Phase 1)Looking for participantsNCT07024160What this trial is testingPhase I Study of MT1011 Injection in Healthy SubjectsWho this might be right forUsed in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation Shaanxi Micot Pharmaceutical Technology Co., Ltd. 40
Post-approval studies (Phase 4)Ended earlyNCT03296033What this trial is testingResidual Anti-Xa Activity After Last Treatment Dose of EnoxaparinWho this might be right forAnticoagulants and Bleeding DisordersSurgeryRegional Anesthesia Morbidity Wake Forest University Health Sciences 122
Not applicableEnded earlyNCT02752607What this trial is testingReduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood ClotsWho this might be right forDeep Vein Thrombosis Dr. Vicky Tagalakis 52